Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Naruo Yoshimura"'
Autor:
MINEHIKO INOMATA, YOSUKE KAWASHIMA, RYOTA SAITO, DAISUKE MORINAGA, HITOMI NOGAWA, MASAMICHI SATO, YOHEI SUZUKI, SATORU YANAGISAWA, TAKASHI KIKUCHI, DAISUKE JINGU, NARUO YOSHIMURA, TOSHIYUKI HARADA, EISAKU MIYAUCHI
Publikováno v:
Cancer Diagnosis & Prognosis; Jul/Aug2024, Vol. 4 Issue 4, p515-520, 6p
Autor:
Takanobu Sasaki, Ryo Nonomura, Toshiharu Tabata, Naruo Yoshimura, Shuko Hata, Hiroki Shimada, Yasuhiro Nakamura
Publikováno v:
Journal of Rural Medicine. 18:42-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::007d6bed58c44992405d93e455891d46
https://doi.org/10.2185/jrm.2022-040
https://doi.org/10.2185/jrm.2022-040
Autor:
MINEHIKO INOMATA, YOSUKE KAWASHIMA, RYOTA SAITO, DAISUKE MORINAGA, HITOMI NOGAWA, MASAMICHI SATO, YOHEI SUZUK, SATORU YANAGISAWA, TAKASHI KIKUCHI, DAISUKE JINGU, NARUO YOSHIMURA, TOSHIYUKI HARADA, EISAKU MIYAUCHI
Publikováno v:
Oncology Letters; Aug2023, Vol. 26 Issue 2, p1-7, 7p
Autor:
Shunichi Sugawara, Eisaku Miyauchi, Ryosuke Chiba, Ryotaro Igusa, Fumiaki Takahashi, Akira Inoue, Atsushi Nakamura, Taku Nakagawa, Naruo Yoshimura, Makoto Maemondo, Kana Watanabe, Masachika Akiyama, Jun Sakakibara-Konishi, Hisashi Tanaka, Tatsuro Fukuhara, Haruo Matsushita, Hiroyuki Minemura, Keisuke Fujimoto, Yukihiro Toi, Yoshiaki Mori
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: The optimal regimen for concurrent chemoradiotherapy (CCRT) of locally advanced non-squamous non-small cell lung cancer (NSCLC) was not definitive. We conducted randomized phase II study, NJLCG0601, and chemoradiotherapy with uracil/tegaf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eec588ddefe6273359c543405d3247d7
https://doi.org/10.21037/tlcr-20-721
https://doi.org/10.21037/tlcr-20-721
Publikováno v:
Journal of Rural Medicine : JRM
Objective: Currently, immune checkpoint inhibitors (ICIs) play a central role in the treatment of lung cancer. However, ICI re-administration is still uncommon, and its utility should be evaluated as early as possible. Patients and Methods: Twenty-fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2d64c1fce316ea02508fa8c5ced620e
https://doi.org/10.2185/jrm.2021-025
https://doi.org/10.2185/jrm.2021-025
Autor:
Misato Nagata, Tatsuo Kimura, Tomohiro Suzumura, Yukimi Kira, Toshiyuki Nakai, Kanako Umekawa, Hidenori Tanaka, Kuniomi Matsuura, Shigeki Mitsuoka, Naruo Yoshimura, Takako Oka, Shinzoh Kudoh, Kazuto Hirata
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2013, Iss 7, Pp 31-39 (2013)
Externí odkaz:
https://doaj.org/article/153e09339a014e469b114b0d23d72974
Autor:
Kazuhisa Asai, Kazuto Hirata, Tatsuo Kimura, Yoshiya Matsumoto, Takashi Yana, Tomoya Kawaguchi, Kenji Sawa, Toshiyuki Nakai, Shigeki Mitsuoka, Naruo Yoshimura
Publikováno v:
American journal of clinical oncology. 44(12)
Objectives We conducted a clinical phase II study to evaluate the modified weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) regimen in pretreated patients with advanced non-small cell lung cancer (NSCLC). Materials and methods This multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ec94d81ade5acacf0afc723c95522d
https://pubmed.ncbi.nlm.nih.gov/34753884
https://pubmed.ncbi.nlm.nih.gov/34753884
Autor:
Akiko Tanaka, Yutaka Nakamura, Isao Ohno, Musashi Abe, Naruo Yoshimura, Emiko Kurosawa, Azusa Otomo, Takashi Ohrui
Publikováno v:
Respiratory Disease Series: Diagnostic Tools and Disease Managements ISBN: 9789811545054
Aspiration is defined as the entry of oropharyngeal or gastric contents into the larynx and the lower respiratory tract. Aspiration is often the result of impaired swallowing, which allows oropharyngeal or gastric contents to enter the lungs, especia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f7bcb064a67e15e5402fd88bea56263
https://doi.org/10.1007/978-981-15-4506-1_3
https://doi.org/10.1007/978-981-15-4506-1_3
Autor:
Tomoya Kawaguchi, Kazuto Hirata, Tatsuo Kimura, Naoki Yoshimoto, Shinzoh Kudoh, Shigeki Mitsuoka, Naruo Yoshimura, Tomohiro Tamiya, Kenji Sawa, Takuhito Tada, Yoshiya Matsumoto, Tomohiro Suzumura, Masako Hosono, Tomonori Hirashima, Hidenori Tanaka
Publikováno v:
American Journal of Clinical Oncology. 41:967-971
A phase I study to determine a recommended dose of thoracic radiotherapy using accelerated hyperfractionation for unresectable non-small cell lung cancer was conducted.We used chemotherapy of a cisplatin doublet and 2 dose levels of radiation with ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b443324e4493837984c2a4d5eb10bbe
https://doi.org/10.1097/coc.0000000000000412
https://doi.org/10.1097/coc.0000000000000412
Autor:
Yukito Ichinose, Takeharu Yamanaka, Hideyuki Harada, Kazuhiko Nakagawa, Junichi Shimizu, Masaaki Kataoka, Yoichi Nakanishi, Nobuyuki Yamamoto, Makoto Nishio, Takeshi Kodaira, Toshiaki Takahashi, Naonobu Kunitake, Takuyo Kozuka, Shinichi Tsutsumi, Naruo Yoshimura, Takashi Seto, Yasumasa Nishimura, Tomonari Sasaki, Hiromoto Kitajima
Publikováno v:
British Journal of Cancer
Background Cisplatin-based chemoradiotherapy is the standard treatment for unresectable, locally advanced non-small-cell lung cancer (NSCLC). This trial evaluated two experimental regimens that combine chemotherapy with concurrent radiotherapy. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28fbeadb176d27cd8526b4549cc2749
http://europepmc.org/articles/PMC6173687
http://europepmc.org/articles/PMC6173687